Zongjiang Luo

449 total citations
19 papers, 321 citations indexed

About

Zongjiang Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zongjiang Luo has authored 19 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Zongjiang Luo's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (5 papers). Zongjiang Luo is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (5 papers). Zongjiang Luo collaborates with scholars based in China, United States and Italy. Zongjiang Luo's co-authors include Jianchu Wang, Wenchuan Li, Jian Pu, Yuan Lu, Wei Wang, Juan Liu, Ying Zhang, Yi‐Chen Chen, Pengyu Chen and Mingwei Wei and has published in prestigious journals such as Journal of Cellular Physiology, Cell Death and Disease and Biomedicine & Pharmacotherapy.

In The Last Decade

Zongjiang Luo

17 papers receiving 318 citations

Peers

Zongjiang Luo
Jiaomeng Pan China
Bentong Yu China
Min Cheng China
Youyi Xiong China
Zhonghai Guan China
Zhaojie Lv China
Miljana Nenkov Germany
Yadong Wang China
Jiaomeng Pan China
Zongjiang Luo
Citations per year, relative to Zongjiang Luo Zongjiang Luo (= 1×) peers Jiaomeng Pan

Countries citing papers authored by Zongjiang Luo

Since Specialization
Citations

This map shows the geographic impact of Zongjiang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongjiang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongjiang Luo more than expected).

Fields of papers citing papers by Zongjiang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongjiang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongjiang Luo. The network helps show where Zongjiang Luo may publish in the future.

Co-authorship network of co-authors of Zongjiang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zongjiang Luo. A scholar is included among the top collaborators of Zongjiang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongjiang Luo. Zongjiang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Luo, Zongjiang, et al.. (2025). Effect of Percutaneous Catheterization and Negative Pressure Drainage in the Treatment of Giant Pancreatic Pseudocyst. Journal of Biosciences and Medicines. 13(1). 77–83.
2.
3.
Luo, Zongjiang, et al.. (2024). A machine learning clinic scoring system for hepatocellular carcinoma based on the Surveillance, Epidemiology, and End Results database. Journal of Gastrointestinal Oncology. 15(3). 1082–1100. 1 indexed citations
4.
Wei, Mingwei, et al.. (2024). Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs. BMC Gastroenterology. 24(1). 142–142. 8 indexed citations
5.
Wei, Mingwei, et al.. (2024). LINC00707 impairs the Natural Killer cell antitumour activity in hepatocellular carcinoma through decreasing YTHDF2 stability. Journal of Cellular and Molecular Medicine. 28(5). e18106–e18106. 8 indexed citations
6.
Bin, Xiaoyun, Zongjiang Luo, Jianchu Wang, & Sufang Zhou. (2023). Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine. 2023(1). 8958962–8958962. 2 indexed citations
7.
Wang, Xiaochen, et al.. (2022). Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma. Cell Death and Disease. 13(3). 223–223. 14 indexed citations
8.
Fan, Bin, et al.. (2021). Circ_0008305‐mediated miR‐660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis. Cancer Medicine. 10(3). 833–842. 15 indexed citations
9.
Luo, Zongjiang, et al.. (2021). CircCAMSAP1 promotes hepatocellular carcinoma progression through miR‐1294/GRAMD1A pathway. Journal of Cellular and Molecular Medicine. 25(8). 3793–3802. 27 indexed citations
10.
Zhang, Ying, Zongjiang Luo, Yi‐Chen Chen, et al.. (2021). GFI1-Mediated Upregulation of LINC00675 as a ceRNA Restrains Hepatocellular Carcinoma Metastasis by Sponging miR-942-5p. Frontiers in Oncology. 10. 607593–607593. 9 indexed citations
11.
12.
Cai, Yi, Jianchu Wang, Wei Wang, et al.. (2020). Identification of Driver Genes Regulating the T-Cell–Infiltrating Levels in Hepatocellular Carcinoma. Frontiers in Genetics. 11. 560546–560546. 4 indexed citations
13.
Wang, Jianchu, et al.. (2020). LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4. Gene Therapy. 27(10-11). 495–504. 23 indexed citations
14.
Wang, Jianchu, Wei Wang, Zongjiang Luo, et al.. (2020). Long Non-coding RNA lnc-GNAT1-1 Suppresses Liver Cancer Progression via Modulation of Epithelial–Mesenchymal Transition. Frontiers in Genetics. 11. 1029–1029. 6 indexed citations
15.
Wang, Jianchu, et al.. (2020). Exosome-transmitted long non-coding RNA SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma. Aging. 12(12). 11550–11567. 52 indexed citations
16.
Wang, Jianchu, et al.. (2019). miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Biomedicine & Pharmacotherapy. 120. 109551–109551. 35 indexed citations
17.
Wang, Jianchu, Jian Pu, Ying Zhang, et al.. (2018). DANCR contributed to hepatocellular carcinoma malignancy via sponging miR‐216a‐5p and modulating KLF12. Journal of Cellular Physiology. 234(6). 9408–9416. 46 indexed citations
18.
Wang, Jianchu, et al.. (2018). LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. Journal of Cellular Physiology. 234(5). 6908–6916. 27 indexed citations
19.
Wang, Jianchu, Wenchuan Li, Zuoming Xu, et al.. (2018). The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma. Journal of Cellular Physiology. 234(7). 10835–10841. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiaomeng Pan Breakdown of academic impact, for papers by Bentong Yu Breakdown of academic impact, for papers by Min Cheng Breakdown of academic impact, for papers by Youyi Xiong Breakdown of academic impact, for papers by Zhonghai Guan Breakdown of academic impact, for papers by Zhaojie Lv Breakdown of academic impact, for papers by Miljana Nenkov Breakdown of academic impact, for papers by Yadong Wang
Rankless by CCL
2026